NEW YORK (GenomeWeb) – Veracyte today said it has launched an early-access program for its Envisia Genomic Classifier test for idiopathic pulmonary fibrosis. The test uses RNA sequencing and machine learning to analyze 190 genes involved in usual interstitial pneumonia, a feature of IPF, with 88 percent specificity and 70 percent sensitivity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.